Get the app
US › Healthcare

Cerus Corporation (CERS)

US · Healthcare · Medical Devices

$2.02-5.16%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
$57.7M
Revenue YoY
+9.5%
Net profit
$-550,000
EPS
$-0.00
EPS estimate
$-0.01
Net margin
-1.0%

EPS came in at -0.00 against a street estimate of -0.01 — a beat of 73.0%.

Key statistics

Market cap
$471.6M
Forward P/E
0.0
P/B
6.73
Book value
$0.33
EPS (TTM)
$-0.04
52-week high
$3.47
52-week low
$1.38
50-day MA
$2.46
200-day MA
$2.45
Beta
1.85

Analyst view

Analysts rate Cerus Corporation a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $5.12.

Shareholding

Insiders
3.61%
Institutions
73.26%

Largest institutional holders

FundStake
BlackRock Inc11.02%
ARK Investment Management LLC8.90%
Vanguard Capital Management, LLC4.25%
Baker Bros Advisors LP3.17%
D. E. Shaw & Co LP2.72%
Geode Capital Management, LLC2.54%
State Street Corp2.36%
RIMA MANAGEMENT, LLC2.29%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cerus Corporation — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.